跳至主要内容
临床试验/NCT00556491
NCT00556491已完成不适用

Minocycline to Prevent Acute Kidney Injury After Cardiac Surgery

Tarek M. El-Achkar2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2007年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
2
主要终点
Development of Post-operative Acute Kidney Injury

研究概览

简要总结

This study proposes to investigate whether treatment with minocycline pre-operatively in patients with mild to moderate chronic kidney disease undergoing cardiac surgery will reduce the occurence of kidney injury.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age over 18 years
  • planned CABG or valvular surgery with cardiopulmonary bypass
  • Serum creatinine available (within 30 days)
  • Estimated GFR 15-90ml/min using the abbreviated MDRD formula (CKD stages 2-4)

排除标准

  • Emergent or urgent surgery (to be performed within the next 36 hours)
  • End stage renal disease, or GFR < 15ml/min (CKD stage 5)
  • Estimated GFR>90ml/min (CKD stage 1 or no CKD)
  • Ongoing infection by positive blood, urine or sputum cultures or pneumonia on CXR
  • Allergy to minocycline or tetracyclines
  • inability to take oral medications
  • use of preoperative vasopressor agents at therapeutic doses
  • Pregnant or lactating females
  • Advanced liver disease by history or exam(cirrhosis, ascitis, jaundice)
  • Rising creatinine meeting the definition of acute kidney injury prior to surgery
  • Neurologic signs or symptoms or history of increased intracranial pressure
  • current participation in another research study involving an investigational drug or device

研究组 & 干预措施

minocycline

Active Comparator

干预措施: minocycline (Drug)

placebo

Placebo Comparator

干预措施: placebo (Drug)

结局指标

主要结局

Development of Post-operative Acute Kidney Injury

时间窗: up to 5 days post cardiac surgery

Participants who develop a Creatinine increase by 0.3 mg/dl (AKIN definition) in any 48 hours time period, within 5 days post-operatively

次要结局

  • Post Operative Hospital Days(30 days post-operative)
  • On Vent >48 Hours(30 days post op)
  • Infections Post Operative(30 days post operative)
  • Stroke Post Operative(30 days post op)
  • Re-operation(30 days post-operative)

研究者

发起方
Tarek M. El-Achkar
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Tarek M. El-Achkar

Associate Professor

St. Louis University

研究点 (2)

Loading locations...

相似试验